Company Aier Eye Hospital Group Co., Ltd.
Equities
300015
CNE100000GR6
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.11 CNY | +0.91% |
|
-1.68% | -16.15% |
| 11-28 | Aier Eye Hospital Group Co., Ltd. Approves Interim Dividend of Year 2025 | CI |
| 11-28 | Aier Eye Hospital Group Co., Ltd. Appoints Liu Duan and Tian Suhua as Independent Director | CI |
Business description: Aier Eye Hospital Group Co., Ltd.
Number of employees: 42,693
Sales by Activity: Aier Eye Hospital Group Co., Ltd.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Medical Industry | 11.9B | 14.97B | 16.07B | 20.31B | 20.91B |
Unallocated Other Business | 12.34M | 27.91M | 41.12M | 54.3M | 72.83M |
Geographical breakdown of sales: Aier Eye Hospital Group Co., Ltd.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Central China | 3.87B | 4.73B | 6.06B | 5.53B | 5.29B |
Unallocated Amount | 1.93B | 2.53B | 2.71B | 3.59B | 3.67B |
East China | 1.59B | 2.08B | 2.31B | 3.11B | 3.32B |
Southwest Region | 1.61B | 1.96B | 2B | 2.59B | 2.72B |
South China | 1.46B | 1.86B | 2.13B | 2.6B | 2.7B |
Europe | 948M | 1.32B | 1.41B | 1.72B | 2.03B |
Northeast China | 916M | 1.11B | - | 1.79B | 1.75B |
Northern China | 794M | 1.06B | 1.17B | 1.57B | 1.66B |
North-West Region | 354M | 490M | 499M | 871M | 902M |
Southeast Asia | 182M | 195M | 308M | 368M | 396M |
Hong Kong | 144M | 139M | 158M | 175M | 153M |
United States | 52.53M | 57.86M | 58.52M | 48.66M | 44.91M |
Intersegment Elimination | -1.93B | -2.53B | -2.71B | -3.59B | -3.67B |
Executive Committee: Aier Eye Hospital Group Co., Ltd.
| Manager | Title | Age | Since |
|---|---|---|---|
Li Li
CEO | Chief Executive Officer | 60 | 2007-11-30 |
Duo Yuan Liu
DFI | Director of Finance/CFO | 63 | 2012-01-05 |
Shi Jun Wu
SEC | Corporate Secretary | 53 | 2013-03-31 |
Zhong Han
DFI | Director of Finance/CFO | 60 | 2007-11-30 |
Yong Mei Zhang
PRN | Corporate Officer/Principal | 45 | 2013-12-31 |
Composition of the Board of Directors: Aier Eye Hospital Group Co., Ltd.
| Director | Title | Age | Since |
|---|---|---|---|
Bang Chen
CHM | Chairman | 60 | 2007-11-30 |
Li Li
BRD | Director/Board Member | 60 | 2007-11-30 |
Zhong Han
BRD | Director/Board Member | 60 | 2007-11-30 |
Shi Jun Wu
CHM | Chairman | 53 | 2007-11-30 |
Yue Mei Guo
BRD | Director/Board Member | 60 | 2019-11-27 |
Shou Chen
BRD | Director/Board Member | 69 | 2019-11-27 |
Xian Li
BRD | Director/Board Member | 59 | 2019-11-27 |
Guo Lei Gao
BRD | Director/Board Member | 47 | 2022-11-29 |
Jun Ping Ning
CHM | Chairman | 47 | 2020-04-13 |
Jiang Tao Su
BRD | Director/Board Member | 35 | 2022-11-29 |
Holdings: Aier Eye Hospital Group Co., Ltd.
| Name | Equities | % | Valuation |
|---|---|---|---|
CLÍNICA BAVIERA, S.A. 73.23% | 11,942,240 | 73.23% | 626,452,412 $ |
ISEC HEALTHCARE LTD. 59.61% | 343,173,790 | 59.61% | 90,089,983 $ |
Company details: Aier Eye Hospital Group Co., Ltd.
Hospitals, Clinics & Primary Care Services
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.91% | -1.68% | -22.85% | -49.59% | 14.64B | |
| +2.50% | +2.50% | +20.08% | +45.44% | 18.57B | |
| +1.31% | -1.23% | -2.18% | +51.77% | 11.27B | |
| +0.14% | -4.89% | +8.97% | +86.96% | 10.77B | |
| +3.08% | +6.91% | -17.96% | -28.21% | 10.12B | |
| +0.85% | -1.31% | +23.32% | +88.48% | 10.1B | |
| -2.55% | -0.74% | -22.16% | - | 8.08B | |
| +2.13% | -1.63% | +22.77% | +204.87% | 7.29B | |
| +0.31% | -2.12% | -3.87% | -46.04% | 5.42B | |
| -0.78% | -2.44% | +45.25% | +147.68% | 4.19B | |
| Average | +0.79% | -0.75% | +5.14% | +55.71% | 10.04B | |
| Weighted average by Cap. | +1.09% | -0.40% | +3.19% | +44.48% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 300015 Stock
- Company Aier Eye Hospital Group Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition